RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 62 filers reported holding RAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,939 | -88.0% | 2,250 | -83.3% | 0.00% | -100.0% |
| Q2 2023 | $16,154 | -85.2% | 13,462 | +8.0% | 0.00% | -75.0% |
| Q1 2023 | $108,918 | +9.3% | 12,462 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $99,696 | +63.4% | 12,462 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $61,000 | -11.6% | 12,462 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $69,000 | +11.3% | 12,462 | +5.5% | 0.00% | +50.0% |
| Q1 2022 | $62,000 | -58.1% | 11,812 | +2.6% | 0.00% | -60.0% |
| Q4 2021 | $148,000 | +3600.0% | 11,512 | +3737.3% | 0.01% | – |
| Q3 2021 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |